- Home
- MPX vs TSHA Comparison
MPX vs TSHA Comparison
Compare MPX & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MPX | TSHA |
|---|---|---|
| Founded | 1965 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.9M | 1.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MPX | TSHA |
|---|---|---|
| Price | $9.04 | $5.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $10.22 |
| AVG Volume (30 Days) | 32.5K | ★ 3.4M |
| Earning Date | 01-29-2026 | 11-04-2025 |
| Dividend Yield | ★ 6.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $227,666,000.00 | $6,310,000.00 |
| Revenue This Year | $3.97 | N/A |
| Revenue Next Year | $13.02 | N/A |
| P/E Ratio | $22.91 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.49 | $1.05 |
| 52 Week High | $9.80 | $5.95 |
Technical Indicators
Market Signals| Indicator | MPX | TSHA |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 67.47 |
| Support Level | $8.06 | $5.22 |
| Resistance Level | $8.75 | $5.54 |
| Average True Range (ATR) | 0.31 | 0.32 |
| MACD | 0.06 | 0.15 |
| Stochastic Oscillator | 89.52 | 92.43 |
Price Performance
Historical ComparisonAbout MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.